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Is Mindfulness for Psychosis harmful? Deconstructing a Myth 
Summary 
 
Mindfulness-based therapies are increasingly available for a range of mental health 
disorders e.g. depression.  However, there remain concerns about the potential for 
mindfulness to exacerbate psychosis, despite a growing body of literature demonstrating 
effectiveness.  This may relate to long-standing perceptions about the suitability of offering 
psychological therapies to people with psychosis. 
 
Is Mindfulness for Psychosis harmful? Deconstructing a Myth 
 
People with psychosis always seem to get everything last. Cognitive therapy for 
depression and anxiety disorders were well-established in the evidence base by the 1980s, 
however Cognitive-Behavioural Therapy (CBT) for psychosis did not make it into clinical 
guidelines in the UK until 20 years later and another 12 years after that in Germany. 
Furthermore, relative to common mental disorders such as anxiety and depression, 
implementation of these guidelines for psychosis has been much more limited in routine clinical 
practice. Similarly, whilst Mindfulness-Based Cognitive Therapy (MBCT) is now 
recommended in the NICE (National Institute for Health and Care Excellence; 
www.nice.org.uk/) guidelines for the prevention of relapse in depression, concerns from 
clinicians that mindfulness is harmful for people with psychosis or can trigger psychotic 
episodes in vulnerable individuals are common (1). 
 
What do we know about harm in mindfulness-based interventions?  
 
Psychological therapy is one of the key pillars in the treatment of a wide range of mental 
illnesses, however information about the potential adverse side effects of psychotherapeutic 
therapies still remain less systematically studied than for medications and medical devices and 
lacks agreed terminology. In this context, decisions about what to provide to whom may be 
influenced more by presumptions about what may happen than be informed by the available 
data.  A variety of factors have been identified as potential adverse effects of psychotherapy 
such as a lack of clinical improvement, symptom deterioration, development of new symptoms, 
fear of seeking future treatment, and maladaptive dependency on therapists (2). Within the 
literature, harm has been defined as any “sustained deterioration that is caused directly by the 
psychological intervention” (2).  
Using this definition from Duggan et al. (2), it is therefore important to distinguish 
between short-term discomfort, which can be considered part of therapeutic growth, and serious 
or long-term harms (serious adverse effects). What we encounter in mindfulness practice is 
often challenging, as we explore deeper through the many layers of our human experience, 
much of which we may be used to keeping shut away. Mindfulness therefore represents a 
journey of re-acquaintance with difficult thoughts and emotions that we may have become 
disconnected from. Short-lived periods of discomfort should therefore be the rule, rather than 
the exception, for people engaging in mindfulness-based interventions (MBIs). However, a 
recent review of clinical trials of MBIs concluded that adverse effects were overall rare (0-10% 
of all participants), and not found to be directly attributable to the mindfulness intervention (3). 
Baer et al. (3) therefore conclude that mindfulness can be uncomfortable without being harmful.   
 
Why specific concerns about mindfulness for psychosis? 
 
Historical concerns about use of mindfulness in psychosis can perhaps be linked to the 
over-reliance on early uncontrolled case study evidence which suggested that people developed 
psychotic episodes after taking part in meditation retreats (1). For example, Walsh and Roche 
(4) report three cases of apparent psychotic relapse in people diagnosed with schizophrenia who 
had taken part in intensive meditation retreat. The meditation retreats were described as 
involving ‘many hours each day of sitting and walking meditation and total silence, without 
communication of any kind (even eye contact)’- (p.1085), and up to ‘18 hours of meditation a 
day’- (p.1086) over the course of a 2-week retreat. This bears little resemblance to the intensity 
and mode of delivery which would be typical of MBIs in mental health care settings. 
Furthermore, we know that sensory deprivation, social isolation, fasting, and sleep deprivation 
may themselves be risk factors for relapse in psychosis, and so these are likely to have been the 
riskiest aspects of the retreat rather than the meditation itself.  
 
What does the current literature on mindfulness for psychosis show? 
 
There have been at least a dozen randomized trials of MBIs for psychosis, with a 
combined sample size of over 1300, as well as several other trials of interventions in which 
mindfulness exercises are used (e.g., acceptance and commitment therapy; compassion focused 
therapy). A recent meta-analyses of trial results indicated that interventions including 
mindfulness as a primary component show beneficial effects in various symptom dimensions 
in contrast to treatment-as-usual and waitlist conditions (5). This indicates that, on average, 
mindfulness is more likely to be beneficial than harmful in psychosis. Furthermore, 
examination of reports of study withdrawals show no evidence of withdrawals arising due to 
psychotic exacerbation from therapy, and trials have consistently shown a similar rate of 
withdrawals between mindfulness and control arms. Studies have also shown rates of treatment 
drop out from MBIs to be no greater than for compared treatments. A series of studies have 
additionally tracked hospital admissions following mindfulness integrated with 
psychoeducation and found that mindfulness was associated with a similar or lower 
hospitalization rates during and following therapy compared with control groups. 
 
What can we take from this? 
 
The belief that it is dangerous to invite people with psychosis to intentionally ‘turn 
towards’ their experiences remains present among clinicians and is perhaps connected to fears 
that it is dangerous to talk to people about their delusional beliefs or unusual experiences 
because this exacerbates their symptoms. There is a rich history of the ‘othering’ of psychotic 
experiences in psychiatry as something enigmatic and apart from normal human experience. 
However, service user advocacy groups have fought hard to overturn this fallacy, to be viewed 
not as less-than-human enigmas but as fully human subjects. Turning towards our inner 
experiences may often be challenging, but there is no rationale for psychotic symptoms, such 
as voices or delusions, to be placed in a separate ‘category’ apart from normal human 
experience. In fact, there is now increasing evidence for the use of mindfulness in the treatment 
psychosis demonstrating safety, acceptability and clinical efficacy. People with psychosis are 
among the most marginalized and discriminated against within society, and unfortunately 
experience significant health inequalities both in their physical health outcomes, e.g. reduced 
life expectancy, and in the insufficient access they often have to evidence-based psychological 
therapies. A paternalistic attitude amongst clinicians about ‘protecting’ people from potentially 
harmful effects of psychological treatments can no longer be considered benevolent if these 
attitudes are unfounded and based on assumptions about the ‘otherness’ of psychotic 
experiences. We argue that early uncontrolled case studies reporting harmful effects of 
meditation for people with psychosis, may have coalesced with ongoing clinician concerns 
about the viability of psychotherapeutic approaches in the treatment of psychosis. This may 
have led to an under-development of the evidence base over the last 20 years, particularly with 
respect to a paucity of large, well-conducted randomized controlled trials of mindfulness for 
psychosis. There is, however, clear interest in the question of the effectiveness of mindfulness 
for psychosis, given that numerous meta-analyses and systematic reviews have been published 
in the field (at least 10 review articles since 2013.) Existing data show that mindfulness for 
psychosis can be implemented safely, if delivered by experienced clinicians with appropriate 
mindfulness training and supervision, within both inpatient and community routine care 
settings. Adaptations to delivering mindfulness for psychosis include delivery in smaller group 
sizes, shorter duration of meditations, avoiding prolonged periods of silence, and using basic 
anchoring techniques and easily accessible and simple language. For future research, we 
suggest a priority should be better systematic assessment of side effects, as well as adverse 
events of mindfulness for psychosis in large trials, in line with the recommendations of Baer et 
al (3), who noted that the potential harms of mindfulness are an under-researched topic. 
This will facilitate an improved understanding of the processes and mechanisms of 
psychotherapeutic change within mindfulness-based interventions for psychosis, to allow the 
field to develop and evolve according to evidence-based practice. In the interim, we recommend 
that clients with psychosis are not denied access to mindfulness-based treatments purely on the 
basis of their diagnosis and/or symptom profile. 
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